Study Shows Potential for Treatment of Obsessive-Compulsive Disorder with Focused Ultrasound
By HospiMedica International staff writers Posted on 05 Jan 2015 |
In the proof-of-concept study, Obsessive-Compulsive Disorder (OCD) patients that did not respond to other medical therapies for OCD (such as pharmacotherapy and cognitive-behavioral therapy) were treated with bilateral thermal capsulotomy using Magnetic Resonance-guided focused ultrasound (MrgFUS) to the anterior internal capsule of the brain.
The patients underwent comprehensive neuropsychological testing at baseline, one week, one month, and six months after treatment using the Yale–Brown Obsessive-Compulsive Scale (Y-BOCS), the Hamilton Rating Scale for Anxiety (HAM-A), and the Hamilton Rating Scale for Depression (HAM-D).
The results of the study in which four patients with disabling medically-refractory OCD were treated with focused ultrasound were published in the Journal of Molecular Psychiatry. The study was conducted by Jin Woo Chang, MD, PhD, at the Yonsei University Medical Center, Seoul, (Seoul, Korea).
The results showed that during the 6-month follow-up period Y-BOCS scores improved by 33%, anxiety decrease by an average of 69.4%, and all patients showed an average decrease of depression by 61.1%. The researchers did not find any physical or neuro-psychological side effects from the treatments.
Related Links:
Yonsei University Medical Center
The patients underwent comprehensive neuropsychological testing at baseline, one week, one month, and six months after treatment using the Yale–Brown Obsessive-Compulsive Scale (Y-BOCS), the Hamilton Rating Scale for Anxiety (HAM-A), and the Hamilton Rating Scale for Depression (HAM-D).
The results of the study in which four patients with disabling medically-refractory OCD were treated with focused ultrasound were published in the Journal of Molecular Psychiatry. The study was conducted by Jin Woo Chang, MD, PhD, at the Yonsei University Medical Center, Seoul, (Seoul, Korea).
The results showed that during the 6-month follow-up period Y-BOCS scores improved by 33%, anxiety decrease by an average of 69.4%, and all patients showed an average decrease of depression by 61.1%. The researchers did not find any physical or neuro-psychological side effects from the treatments.
Related Links:
Yonsei University Medical Center
Latest Critical Care News
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis
- World's First AI-Powered Sepsis Alert System Detects Sepsis in One Minute
- Smartphone Magnetometer Uses Magnetized Hydrogel to Measure Biomarkers for Disease Diagnosis
- New Technology to Revolutionize Valvular Heart Disease Care